Prevalence of Multidrug-Resistant Organisms in Healthy Adults in Shenzhen, China-Reference-Cited by-同舟云学术

Prevalence of Multidrug-Resistant Organisms in Healthy Adults in Shenzhen, China

Published:2023-04-01 Issue:2 Volume:21 Page:122-129
ISSN:2326-5094
Container-title:Health Security
language:en
Short-container-title:Health Security

Author:

Liu Ding¹,Li Guiqiu²,Hong Zhifan²,Zhang Cong³,Zhu Ning⁴,Tan Yan⁵,Gao Ting⁶

Affiliation:

1. Ding Liu, MS, is a Senior Scientist, Shenzhen Xbiome Biotech Ltd, Shenzhen, People's Republic of China.

2. Zhifan Hong is a Scientist, Shenzhen Xbiome Biotech Ltd, Shenzhen, People's Republic of China.

3. Cong Zhang, MS, is a Senior Scientist, Shenzhen Xbiome Biotech Ltd, Shenzhen, People's Republic of China.

4. Ning Zhu, PhD, is a Senior Manager, Shenzhen, People's Republic of China.

5. Yan Tan, PhD, is Chief Executive Officer, Shenzhen Xbiome Biotech Ltd, Shenzhen, People's Republic of China.

6. Ting Gao, PhD, is CMC Director, Shenzhen Xbiome Biotech Ltd, Shenzhen, People's Republic of China.

Publisher

Mary Ann Liebert Inc

Subject

Health, Toxicology and Mutagenesis,Management, Monitoring, Policy and Law,Public Health, Environmental and Occupational Health,Safety Research,Emergency Medicine,Health (social science)

Link

https://www.liebertpub.com/doi/pdf/10.1089/hs.2022.0111

Reference32 articles.

1. Screening for methicillin-resistant Staphylococcus aureus: A comparative effectiveness review

2. Global Spread of Carbapenemase-producingEnterobacteriaceae

3. Antibiotic Pollution in the Environment: From Microbial Ecology to Public Policy

4. Extensively drug-resistant carbapenemase-producing Enterobacteriaceae: an emerging challenge for clinicians and healthcare systems

5. Colonization by multidrug-resistant organisms in long-term care facilities in Italy: a point-prevalence study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interpretable Machine Learning for Early Prediction of Multidrug-Resistant Organism Infection：A Discovery and Validation Study;2023-10-10